Characteristics of incident female breast cancer in Lebanon, 1990–2013: Descriptive study of 612 cases from a hospital tumor registry

Chahine, Georges; Rassy, Elie; Khazzaka, Aline; Saleh, Khalil; Rassy, Nathalie Al; Khalifé, Nadine; Atallah, David

doi:10.1016/j.canep.2015.03.008

Cited by 18 publications

(15 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This change may be attributed to improvements in the local healthcare system 59. Similarly, a study of a Lebanese hospital showed a small improvement in the early diagnosis rate (CS 0 + I), which was 23.8% from 1990-1995 but changed to 25.8% from 2008-2013 25. A study conducted in Iran did not show temporal changes in the early-stage diagnoses between 1994-1997 and 2006-2009, which were 13% and 13.9%, respectively 56.…”

Section: Resultsmentioning

confidence: 99%

Breast cancer screening in developing countries

Vieira¹,

Biller²,

Uemura³

et al. 2017

Clinics

171

100

View full text Add to dashboard Cite

Developing countries have limited healthcare resources and use different strategies to diagnose breast cancer. Most of the population depends on the public healthcare system, which affects the diagnosis of the tumor. Thus, the indicators observed in developed countries cannot be directly compared with those observed in developing countries because the healthcare infrastructures in developing countries are deficient. The aim of this study was to evaluate breast cancer screening strategies and indicators in developing countries.A systematic review and the Population, Intervention, Comparison, Outcomes, Timing, and Setting methodology were performed to identify possible indicators of presentation at diagnosis and the methodologies used in developing countries. We searched PubMed for the terms “Breast Cancer” or “Breast Cancer Screening” and “Developing Country” or “Developing Countries”.In all, 1,149 articles were identified. Of these articles, 45 full articles were selected, which allowed us to identify indicators related to epidemiology, diagnostic intervention (diagnostic strategy, diagnostic infrastructure, percentage of women undergoing mammography), quality of intervention (presentation of symptoms at diagnosis, time to diagnosis, early stage disease), comparisons (trend curves, subpopulations at risk) and survival among different countries.The identification of these indicators will improve the reporting of methodologies used in developing countries and will allow us to evaluate improvements in public health related to breast cancer.

show abstract

Section: Resultsmentioning

confidence: 99%

Breast cancer screening in developing countries

Vieira¹,

Biller²,

Uemura³

et al. 2017

Clinics

171

100

View full text Add to dashboard Cite

show abstract

“…The recommended starting age for routine BCS varies widely as well due to lack of government recommendations [14][15][16][17][18][19]. However, a few proportion (2.2%) of aged women (i.e., aged 40-69 years) had utilised screening services in LRCs [20].…”

Section: Introductionmentioning

confidence: 99%

“…Despite the benefits of screening, the utilisation of BCS services are relatively low in LRCs, compared to high income countries (HICs) [ 11 , 12 ]. Factors that can influence participation in BCS services vary in different countries’ settings [ 20 ]. Some studies have found that socio-economic factors (such as age distribution, marital status, socioeconomics group) are the leading driving force behind utilising BCS services in LRCs [ 11 , 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

Distribution and predictors associated with the use of breast cancer screening services among women in 14 low-resource countries

et al. 2020

View full text Add to dashboard Cite

Background Breast cancer is one of the leading public health problem globally, especially in low-resource countries (LRCs). Breast cancer screening (BCS) services are an effective strategy for early determining of breast cancer. Hence, it is imperative to understand the utilisation of BCS services and their correlated predictors in LRCs. This study aims to determine the distribution of predictors that significantly influence the utilisation of BCS services among women in LRCs. Methods The present study used data on 140,974 women aged 40 years or over from 14 LRCs. The data came from country Demographic and Health Surveys (DHS) between 2008 and 2016. Multivariate logistic regression analysis was employed to investigate the significant predictors that influence the use of BCS services. Results The utilisation of BCS services was 15.41%, varying from 81.10% (95% CI: 76.85–84.73%) in one European country, to 18.61% (95% CI: 18.16 to 19.06%) in Asian countries, 14.30% (95% CI: 13.67–14.96%) in American countries, and 14.29% (95% CI: 13.87–14.74%). Factors that were significantly associated to increase the use of BCS services include a higher level of education (OR = 2.48), advanced age at first birth (> 25 years) (OR = 1.65), female-headed households (OR = 1.65), access to mass media communication (OR = 1.84), health insurance coverage (OR = 1.09), urban residence (OR = 1.20) and highest socio-economic status (OR = 2.01). However, obese women shown a significantly 11% (OR = 0.89) lower use of BSC services compared to health weight women. Conclusion The utilisation of BCS services is low in many LRCs. The findings of this study will assist policymakers in identifying the factors that influence the use of BCS services. To increase the national BCS rate, more attention should be essential to under-represented clusters; in particular women who have a poor socioeconomic clusters, live in a rural community, have limited access to mass media communication, and are have a low level educational background. These factors highlight the necessity for a new country-specific emphasis of promotional campaigns, health education, and policy targeting these underrepresented groups in LRCs.

show abstract

“…Estrogen-receptor positive BC accounts for 70% of Western women whilst overall Arab women present a majority in estrogen-receptor negative BC with a large prevalence of triple negative BC (20% in the UAE to 39% in Saudi women) with Lebanese women being an exception (9.3%), with rates comparable as to that of European (9%) women. In addition, HER2 overexpression is much more prevalent in the Arab region (39.5% in Lebanon) than in other parts of the world [16,30,31].…”

Section: Biological Characteristics Of Breast Cancermentioning

confidence: 99%

The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors

Nemeir

Saab

Hleihel

et al. 2019

Sensors

View full text Add to dashboard Cite

Breast Cancer is one of the world’s most notorious diseases affecting two million women in 2018 worldwide. It is a highly heterogeneous disease, making it difficult to treat. However, its linear progression makes it a candidate for early screening programs, and the earlier its detection the higher the chance of recovery. However, one key hurdle for breast cancer screening is the fact that most screening techniques are expensive, time-consuming, and cumbersome, making them impractical for use in several parts of the world. One current trend in breast cancer detection has pointed to a possible solution, the use of salivary breast cancer biomarkers. Saliva is an attractive medium for diagnosis because it is readily available in large quantities, easy to obtain at low cost, and contains all the biomarkers present in blood, albeit in lower quantities. Affinity sensors are devices that detect molecules through their interactions with biological recognition molecules. Their low cost, high sensitivity, and selectivity, as well as rapid detection time make them an attractive alternative to traditional means of detection. In this review article, we discuss the current status of breast cancer diagnosis, its salivary biomarkers, as well as the current trends in the development of affinity sensors for their detection.

show abstract

Characteristics of incident female breast cancer in Lebanon, 1990–2013: Descriptive study of 612 cases from a hospital tumor registry

Cited by 18 publications

References 19 publications

Breast cancer screening in developing countries

Breast cancer screening in developing countries

Distribution and predictors associated with the use of breast cancer screening services among women in 14 low-resource countries

The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors

Contact Info

Product

Resources

About